author-photo

Adam Sampson-Johannes

Onyx Pharmaceuticals

9

Papers

3105

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Developing Novel Oncolytic Adenoviruses through Bioselection

2003 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (50)
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

2000 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (519)
Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status.

2000 Gene Therapy
Show All
- Source
- Cite
- Save
Citations (61)
Process for destroying tumors and tumor associated endothelial cells using adenoviral mutants.

1999
Show All
- Source
- Cite
- Save
Citations (0)
Destruction selective et diagnostic de cellules neoplasiques a p53

1998
- Adam Sampson-Johannes
- David Kirn
Show All
- Source
- Cite
- Save
Citations (0)
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents.

1997 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (850)
ONYX-015: An adenovirus attenuated in the E1B-55KD gene selectively replicates in, and causes lysis of, P53- tumor cells

1997 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
The Candidates Speak: At the invitation of Science, President Bill Clinton and Senator Bob Dole have responded to a series of questions regarding science policy

1996 Science
Show All
- Source
- Cite
- Save
Citations (2)
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

1996 Science
Show All
- Source
- Cite
- Save
Citations (1623)